|1.||Tumakaev, R F: 2 articles (05/2010 - 02/2006)|
|2.||Svatko, L G: 2 articles (01/2008 - 01/2001)|
|3.||Galiautdinova, A Iu: 2 articles (09/2002 - 11/2000)|
|4.||Ziganshina, L E: 2 articles (09/2002 - 11/2000)|
|5.||Valeeva, I Kh: 2 articles (09/2002 - 11/2000)|
|6.||Arveladze, G: 1 article (07/2015)|
|7.||Geladze, N: 1 article (07/2015)|
|8.||Khachapuridze, N: 1 article (07/2015)|
|9.||Kapanadze, N: 1 article (07/2015)|
|10.||Bakhtadze, S: 1 article (07/2015)|
11/01/2000 - "[Comparative study of dimephosphon and xidiphone efficacy in steroid-induced osteoporosis in rats]."
09/01/2002 - "The efficacy of monophosphonate dimephosphon and diphosphonate xydiphon was compared by experiments in rats with an osteoporosis model induced by the chronic administration of prednisolone. "
09/01/2002 - "[Comparative study of the effect of dimephosphon monophosphonate and xydiphone biphosphonate on the histomorphometric indices of rat vertebra in a model of glucocorticosteroid osteoporosis]."
11/01/2000 - "The efficacy of dimephosphon in comparison with xydiphone was studied in rats with an osteoporosis model induced by prednisolone administration at a daily dose of 50 mg/kg over a period of 14 days. "
05/01/1992 - "The effects of dimephosphon combined with nonsteroidal anti-inflammatory drugs were studied in rats and mice with experimental inflammation. "
01/01/1990 - "The effects of dimephosphon on the models of inflammation which permitted the separation of the exudative and proliferative phases were studied on rats. "
05/01/1988 - "The antihistamine and antiserotonin activity of dimephosphon was shown on models of paw edema caused by subplantar administration of mediators and modulators of inflammation. "
|2.||Etidronic Acid (HEDP)
|9.||Hypoglycemic Agents (Hypoglycemics)